SANOFI (1SAN.MI) Stock Fundamental Analysis

BIT:1SAN • FR0000120578

78.1 EUR
+0.23 (+0.3%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, 1SAN scores 5 out of 10 in our fundamental rating. 1SAN was compared to 52 industry peers in the Pharmaceuticals industry. While 1SAN is still in line with the averages on profitability rating, there are concerns on its financial health. 1SAN has a correct valuation and a medium growth rate. 1SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • 1SAN had positive earnings in the past year.
  • Each year in the past 5 years 1SAN has been profitable.
  • Each year in the past 5 years 1SAN had a positive operating cash flow.
1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCF1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With a decent Return On Assets value of 10.63%, 1SAN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
  • 1SAN has a Return On Equity of 18.84%. This is in the better half of the industry: 1SAN outperforms 65.38% of its industry peers.
  • 1SAN has a better Return On Invested Capital (13.35%) than 65.38% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 14.45%.
  • The last Return On Invested Capital (13.35%) for 1SAN is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
1SAN.MI Yearly ROA, ROE, ROIC1SAN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1SAN has a better Profit Margin (20.63%) than 80.77% of its industry peers.
  • In the last couple of years the Profit Margin of 1SAN has declined.
  • 1SAN has a Operating Margin of 23.61%. This is comparable to the rest of the industry: 1SAN outperforms 57.69% of its industry peers.
  • In the last couple of years the Operating Margin of 1SAN has grown nicely.
  • 1SAN has a Gross Margin (72.29%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
1SAN.MI Yearly Profit, Operating, Gross Margins1SAN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1SAN is still creating some value.
  • 1SAN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1SAN has been reduced compared to 5 years ago.
  • 1SAN has a worse debt/assets ratio than last year.
1SAN.MI Yearly Shares Outstanding1SAN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1SAN.MI Yearly Total Debt VS Total Assets1SAN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that 1SAN is not too dependend on debt financing.
  • 1SAN has a Debt to Equity ratio of 0.18. This is in the better half of the industry: 1SAN outperforms 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.68
WACC7.95%
1SAN.MI Yearly LT Debt VS Equity VS FCF1SAN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1SAN has a Current Ratio of 1.06. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.06, 1SAN is doing worse than 75.00% of the companies in the same industry.
  • 1SAN has a Quick Ratio of 1.06. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1SAN has a worse Quick ratio (0.30) than 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
1SAN.MI Yearly Current Assets VS Current Liabilites1SAN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • The Earnings Per Share has been growing slightly by 5.58% on average over the past years.
  • The Revenue has been growing slightly by 5.49% in the past year.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • Based on estimates for the next years, 1SAN will show a small growth in Earnings Per Share. The EPS will grow by 7.70% on average per year.
  • Based on estimates for the next years, 1SAN will show a small growth in Revenue. The Revenue will grow by 4.86% on average per year.
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1SAN.MI Yearly Revenue VS Estimates1SAN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
1SAN.MI Yearly EPS VS Estimates1SAN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.99, the valuation of 1SAN can be described as very reasonable.
  • 86.54% of the companies in the same industry are more expensive than 1SAN, based on the Price/Earnings ratio.
  • 1SAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.99.
  • The Price/Forward Earnings ratio is 9.24, which indicates a very decent valuation of 1SAN.
  • 1SAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1SAN is cheaper than 92.31% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, 1SAN is valued rather cheaply.
Industry RankSector Rank
PE 9.99
Fwd PE 9.24
1SAN.MI Price Earnings VS Forward Price Earnings1SAN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1SAN.MI Per share data1SAN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • 1SAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)1.79
EPS Next 2Y6.92%
EPS Next 3Y8.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.22%, 1SAN is a good candidate for dividend investing.
  • 1SAN's Dividend Yield is rather good when compared to the industry average which is at 1.91. 1SAN pays more dividend than 92.31% of the companies in the same industry.
  • 1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 5.22%

5.2 History

  • The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 34.36% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
  • 1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
1SAN.MI Yearly Income VS Free CF VS Dividend1SAN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
1SAN.MI Dividend Payout.1SAN.MI Dividend Payout, showing the Payout Ratio.1SAN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

BIT:1SAN (2/17/2026, 7:00:00 PM)

78.1

+0.23 (+0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap188.63B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts77.33
Price Target100.43 (28.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.22%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-4.71%
PT rev (3m)-5.87%
EPS NQ rev (1m)3.11%
EPS NQ rev (3m)2.34%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-1.58%
Revenue NQ rev (1m)1.41%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 9.99
Fwd PE 9.24
P/S 2.82
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 42.91
EV/EBITDA N/A
EPS(TTM)7.82
EY10.01%
EPS(NY)8.45
Fwd EY10.82%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)1.23
PEG (5Y)1.79
Graham Number73.06
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.95%
ROIC/WACC1.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y7.52%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / 1SAN.MI FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI.


What is the valuation status of SANOFI (1SAN.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (1SAN.MI) has a profitability rating of 6 / 10.


How financially healthy is SANOFI?

The financial health rating of SANOFI (1SAN.MI) is 3 / 10.


What is the expected EPS growth for SANOFI (1SAN.MI) stock?

The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 8.1% in the next year.